Table 3.
Clinical Outcomes*
| Total (N=1020) | Direct stenting (N=672) | Stenting with pre-dilation (N=348) | P value | |
|---|---|---|---|---|
| Long-term (16-month) clinical outcomes | ||||
| Major adverse cardiac events | 101 (9.9) | 49 (7.6) | 52 (13.8) | 0.001 |
| Death | 17 (1.7) | 9 (1.4) | 8 (2.1) | 0.380 |
| Cardiac death | 10 (1.0) | 4 (0.7) | 6 (1.6) | 0.010 |
| Myocardial infarction | 14 (1.4) | 5 (0.8) | 9 (2.4) | 0.032 |
| Q-wave myocardial infarction | 2 (0.2) | 1 (0.2) | 1 (0.3) | 1.0 |
| Target lesion revascularization | 51 (5.0) | 26 (4.0) | 25 (6.6) | 0.065 |
| Target vessel revascularization | 68 (6.7) | 36 (5.6) | 32 (8.5) | 0.071 |
| Any repeat percutaneous revascularization | 124 (12.2) | 69 (10.7) | 55 (14.6) | 0.065 |
| Coronary artery bypass grafting | 7 (0.7) | 1 (0.2) | 6 (1.6) | 0.012 |
| Stroke | 7 (0.7) | 3 (0.5) | 4 (1.1) | 0.264 |
| Definite stent thrombosis | 3 (0.3) | 1 (0.2) | 2 (0.5) | 0.284 |
| Angiographic outcomes | ||||
| Angiographic follow-up | 338 (33.1) | 191 (29.7) | 147 (39.1) | 0.002 |
| Timing of angiographic follow-up | 9.7±8.4 | 10.5±8.4 | 8.7±8.2 | 0.056 |
| Binary angiographic restenosis | 66 (6.5) | 29 (4.5) | 37 (9.8) | <0.001 |
*
reported as n (%)